Title: New Drug Updates for Multiple Myeloma

Speaker: Ryan Miller, PharmD, BCOP (Vanderbilt University Medical Center)

This session was originally presented at the 2022 Tandem Meetings Pharmacist Conference.

Learning Objectives: 

• Outline the role of monoclonal antibody based four drug regimens for newly diagnosed multiple myeloma
• Describe the mechanism of action of newly approved agents for relapsed/refractory multiple myeloma
• Examine the efficacy and safety data for newly approved anti-BCMA agents for relapsed / refractory multiple myeloma
• Discuss immunotherapy agents in the pipeline for the treatment of multiple myeloma

This session has been accredited for 1 hour of BCOP Credit by HOPA. In order to claim BCOP credit, learners must view the presentation in its entirety and pass the quiz with a minimum score of 80%. You will only have two attempts to pass the quiz.